Cargando…

Few and Far Between: How HIV May Be Evading Antibody Avidity

Detalles Bibliográficos
Autores principales:	Klein, Joshua S., Bjorkman, Pamela J.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877745/ https://www.ncbi.nlm.nih.gov/pubmed/20523901 http://dx.doi.org/10.1371/journal.ppat.1000908

Ejemplares similares

Buprenorphine: Far Beyond the “Ceiling”
por: Infantino, Rosmara, et al.
Publicado: (2021)

Harnessing Avidity: Quantifying the Entropic and Energetic Effects of Linker Length and Rigidity for Multivalent Binding of Antibodies to HIV-1
por: Einav, Tal, et al.
Publicado: (2019)

How far along are we in revealing the connection between metformin and colorectal cancer?
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2021)

Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
por: Cairney, Paul, et al.
Publicado: (2017)

Nonfamilial Multiple Trichoepithelioma: Few and Far Between
por: Sehrawat, Manu, et al.
Publicado: (2016)

Why are there so few (or so many) circulating coronaviruses?
por: Rice, Benjamin L., et al.
Publicado: (2021)

“Programmed Cell Death: A Process of Death for Survival” – How Far Terminology Pertinent for Cell Death in Unicellular Organisms
por: Pandey, Shiv Shanker, et al.
Publicado: (2018)

Twenty Years after De Ley and Blaxter—How Far Did We Progress in Understanding the Phylogeny of the Phylum Nematoda?
por: Ahmed, Mohammed, et al.
Publicado: (2021)

Angiokeratoma circumscriptum neviforme: An entity, few and far between
por: Das, Anupam, et al.
Publicado: (2014)

Microbiology service centralization: a step too far
por: Dancer, S.J., et al.
Publicado: (2015)

How few and far between? Examining the effects of probe rate on self-reported mind wandering
por: Seli, Paul, et al.
Publicado: (2013)

Is a Pacific Coexistence Between Virus and Host the Unexploited Path That May Lead to an HIV Functional Cure?
por: Fior, Jonathan
Publicado: (2013)

COVID-19: Situation of European Countries so Far
por: Pillai, Sunitha, et al.
Publicado: (2020)

Increasing Melanoma—Too Many Skin Cell Damages or Too Few Repairs?
por: Hallberg, Örjan, et al.
Publicado: (2013)

How Lazy Reading and Semantic Sloppiness May Harm Progress in Synucleinopathy Research
por: Bezard, Erwan
Publicado: (2022)

Gestation-Based Viability–Difficult Decisions with Far-Reaching Consequences
por: Thomas, Sumesh, et al.
Publicado: (2021)

The Cat and Mouse of HIV-1 Antibody Escape
por: Mascola, John R.
Publicado: (2009)

How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine
por: Slobod, Karen S., et al.
Publicado: (2020)

So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020
por: Rodrigues, Manuel, et al.
Publicado: (2019)

A unified health algorithm that teaches itself to improve health outcomes for every individual: How far into the future is it?
por: Laroia, Gaurav, et al.
Publicado: (2022)

Bittersweet Sugars: How Unusual Glycan Structures May Connect Epithelial-to-Mesenchymal Transition and Multidrug Resistance in Cancer
por: da Fonseca, Leonardo Marques, et al.
Publicado: (2023)

Rural medical students at urban medical schools: Too few and far between?
por: Hensel, Jennifer M, et al.
Publicado: (2007)

How far from the SNP may the causative genes be?
por: Brodie, Aharon, et al.
Publicado: (2016)

How to avoid pitfalls in antibody use
por: Pauly, Diana, et al.
Publicado: (2015)

“Rational Vaccine Design” for HIV Should Take into Account the Adaptive Potential of Polyreactive Antibodies
por: Dimitrov, Jordan D., et al.
Publicado: (2011)

Engineering pan–HIV-1 neutralization potency through multispecific antibody avidity
por: Rujas, Edurne, et al.
Publicado: (2022)

Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis
por: Gach, Johannes S., et al.
Publicado: (2017)

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)

How persister bacteria evade antibiotics, prolong infections
por: Madhusoodanan, Jyoti
Publicado: (2022)

Forensic DNA phenotyping in Europe: How far may it go?
por: Zieger, Martin
Publicado: (2022)

Keeping your armour intact: How HIV-1 evades detection by the innate immune system
por: Maelfait, Jonathan, et al.
Publicado: (2014)

Avidity of anti-phospholipid antibodies in relation to their levels
por: FIALOVÁ, LENKA, et al.
Publicado: (2020)

Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections
por: Jones, Joshua D
Publicado: (2015)

If so many are “few,” how few are “many”?
por: Heim, Stefan, et al.
Publicado: (2015)

How to make models more useful
por: Barton, C. Michael, et al.
Publicado: (2022)

Hiding Behind Machines: Artificial Agents May Help to Evade Punishment
por: Feier, Till, et al.
Publicado: (2022)

COVID-19 and the liver: What do we know so far?
por: Nasa, Prashant, et al.
Publicado: (2021)

Far and Few Between: Early Onset Multiple Myeloma in a 26-Year-Old Female
por: Khan, Abdul Wali, et al.
Publicado: (2020)

HIV-1 mutates to evade IFITM1 restriction
por: Ding, Shilei, et al.
Publicado: (2014)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
por: Li, Kan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fn1c38crc2g1isjij282uruss9